Comprehensive Real-World Claims Analysis Identifies an Estimated 154,986 Patients Diagnosed With DSAP in the U.S.
RESTORE is a multicenter, randomized, double-blind, placebo-controlled Phase 3 registrational study evaluating the efficacy and safety of NVG-291 in adults living with chronic cervical ...
In an exploratory analysis of participants with baseline NfL levels at or above the median (n=13), mean change in NfL levels was ~ 5.7 pg/mL over 12 weeks. GFAP levels were stable over the first 12 ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced ...
Prodigy Silk is Kraig Labs' production arm, a vertically integrated operation that rears, harvests, and processes recombinant spider silk. The additional capital will support new capacity, strengthen ...
A Phase 1b cohort in eosinophilic esophagitis (EoE) is enrolling 50 patients with top-line data anticipated in Q3 2027. Additionally, we are also on track to initiate Phase 2 development in vitiligo ...
New UK comparative study data assessing patient preferences between trainer devices suggest EURneffy ® is viewed as less burdensome than adrenaline auto-injectors (AAIs) 1; After ...
Laru-zova demonstrated a favorable safety and tolerability profile, consistent with prior trials ...
The platform uses resonant inductive power transfer technology to transfer electricity across an air gap without physical connectors. The system is designed to deliver charging power of up to 10 kW ...
Sutro Participant: Alice Yam, Ph.D. Presenter: Daniel Calarese, Ph.D. Following the event, the content will be made available in the Scientific Publications section of Sutro Biopharma’s website at www ...
Current CEO Jeffrey M. Dayno, M.D., will retire at the end of the year following a nine-year tenure at the Company, including as Chief Medical Officer, and step down as a member of the Board.
Yuichi Iwaki, M.D., Ph.D. Founder, Chairman, CEO, and President MediciNova, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results